Successful therapeutic use of rituximab in refractory membranous glomerulonephritis
- 1 July 2006
- journal article
- case report
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 66 (7) , 54-57
- https://doi.org/10.5414/cnp66054
Abstract
We present the case of a 57-year-old man with nephrotic syndrome secondary to idiopathic membranous glomerulonephritis unsuccessfully treated with angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor antagonist (ARA), prednisone and chlorambucil. After treatment with rituximab, we observed a progressive decrease of proteinuria and normalization of serum albumin. 18 months after treatment, he remained in remission. No adverse reactions to rituximab were noted throughout follow-up.Keywords
This publication has 0 references indexed in Scilit: